93 related articles for article (PubMed ID: 27061569)
1. Multiple human papillomavirus infections and type-competition in women from a clinic attendee population in China.
Nie J; Liu J; Xie H; Sun Z; Zhao J; Chen Q; Liu Y; Huang W; Ruan Q; Wang Y
J Med Virol; 2016 Nov; 88(11):1989-98. PubMed ID: 27061569
[TBL] [Abstract][Full Text] [Related]
2. HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes.
Senapati R; Nayak B; Kar SK; Dwibedi B
PLoS One; 2017; 12(11):e0187844. PubMed ID: 29161285
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and genotype distribution of cervical human papillomavirus (HPV) among women in urban Tianjin, China.
Chen X; Wallin KL; Duan M; Gharizadeh B; Zheng B; Qu P
J Med Virol; 2015 Nov; 87(11):1966-72. PubMed ID: 26073652
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes.
Barzon L; Squarzon L; Masiero S; Pacenti M; Marcati G; Mantelli B; Gabrielli L; Pascucci MG; Lazzarotto T; Caputo A; Palù G
Vaccine; 2014 Sep; 32(41):5357-62. PubMed ID: 25045814
[TBL] [Abstract][Full Text] [Related]
5. Genotypes and prevalence of HPV single and multiple concurrent infections in women with HSIL.
Beca F; Pinheiro J; Rios E; Pontes P; Amendoeira I
Diagn Cytopathol; 2014 Nov; 42(11):919-23. PubMed ID: 24623593
[TBL] [Abstract][Full Text] [Related]
6. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
Fei M; Li J; Du J; You J; Zhang S; He W; Kang L; Zhao F; Qiao Y; Si Y; Fan X; Chen W
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):514-8. PubMed ID: 25059358
[TBL] [Abstract][Full Text] [Related]
7. Type-Specific Human Papillomavirus Distribution in Invasive Squamous Cervical Carcinomas in Tunisia and Vaccine Impact.
Ennaifer E; Salhi F; Laassili T; Fehri E; Ben Alaya N; Guizani I; Boubaker S
Asian Pac J Cancer Prev; 2015; 16(15):6769-72. PubMed ID: 26434909
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and genotype distribution of human papillomavirus among women from Henan, China.
Wang XC; Sun LQ; Ma L; Li HX; Wang XL; Wang X; Yun T; Meng NL; Lv DL
Asian Pac J Cancer Prev; 2014; 15(17):7333-6. PubMed ID: 25227838
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trial.
Toft L; Storgaard M; Müller M; Sehr P; Bonde J; Tolstrup M; Østergaard L; Søgaard OS
J Infect Dis; 2014 Apr; 209(8):1165-73. PubMed ID: 24273179
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of human papillomavirus and its genotype among 1336 invasive cervical cancer patients in Hunan province, central south China.
Wang L; Wu B; Li J; Chen L
J Med Virol; 2015 Mar; 87(3):516-21. PubMed ID: 25604457
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of carcinogenic human papillomavirus infection in Suzhou: Epidemiology, vaccine evaluation, and associated diseases.
Li WJ; Xu HX; Chen ZH; Xu WD; Wu YJ
J Med Virol; 2017 May; 89(5):895-901. PubMed ID: 27696465
[TBL] [Abstract][Full Text] [Related]
13. Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial.
Krajden M; Cook D; Yu A; Chow R; Su Q; Mei W; McNeil S; Money D; Dionne M; Palefsky J; Karunakaran K; Kollmann T; Ogilvie G; Petric M; Dobson S
Vaccine; 2014 Jan; 32(5):624-30. PubMed ID: 24055350
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial.
Wu T; Hu YM; Li J; Chu K; Huang SJ; Zhao H; Wang ZZ; Yang CL; Jiang HM; Wang YJ; Lin ZJ; Pan HR; Sheng W; Wei FX; Li SW; Wang Y; Zhu FC; Li CG; Zhang J; Xia NS
Vaccine; 2015 Jul; 33(32):3940-6. PubMed ID: 26100924
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease.
Chaturvedi AK; Katki HA; Hildesheim A; Rodríguez AC; Quint W; Schiffman M; Van Doorn LJ; Porras C; Wacholder S; Gonzalez P; Sherman ME; Herrero R;
J Infect Dis; 2011 Apr; 203(7):910-20. PubMed ID: 21402543
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia.
Krajden M; Karunakaran K; So S; Palefsky JM; Sharma R; Cook D; Yu A; Chow R; Dobson S; Ogilvie GS; Petric M
Clin Vaccine Immunol; 2009 Dec; 16(12):1840-3. PubMed ID: 19828766
[TBL] [Abstract][Full Text] [Related]
17. Age distribution of human papillomavirus infection and neutralizing antibodies in healthy Chinese women aged 18-45 years enrolled in a clinical trial.
Wei LH; Su YY; Hu YM; Li RC; Chen W; Pan QJ; Zhang X; Zhao FH; Zhao YQ; Li Q; Hong Y; Zhao C; Li MQ; Liu WY; Li CH; Guo DP; Ke LD; Lin BZ; Lin ZJ; Chen S; Sheng W; Zheng ZZ; Zhuang SJ; Zhu FC; Pan HR; Li YM; Huang SJ; Zhang J; Qiao YL; Wu T; Xia NS
Clin Microbiol Infect; 2020 Aug; 26(8):1069-1075. PubMed ID: 31904566
[TBL] [Abstract][Full Text] [Related]
18. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
Bao YP; Li N; Smith JS; Qiao YL
Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles.
Kines RC; Zarnitsyn V; Johnson TR; Pang YY; Corbett KS; Nicewonger JD; Gangopadhyay A; Chen M; Liu J; Prausnitz MR; Schiller JT; Graham BS
PLoS One; 2015; 10(3):e0120797. PubMed ID: 25785935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
